| Dr Jean M Gerhard, MD | |
|
3004 Communications Pkwy, #200, Plano, TX 75093-8909 | |
| (972) 468-8158 | |
| (972) 473-4808 |
| Full Name | Dr Jean M Gerhard |
|---|---|
| Gender | Female |
| Speciality | Obstetrics & Gynecology |
| Location | 3004 Communications Pkwy, Plano, Texas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255390357 | NPI | - | NPPES |
| 139001503 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | K6582 (Texas) | Primary |
| Entity Name | Obhg Texas Holdings Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083917769 PECOS PAC ID: 3577713072 Enrollment ID: O20121018000279 |
News Archive
In new research appearing in the prestigious journal Nature Biotechnology, an international research team led by The Hebrew University of Jerusalem describes a new technique for growing human hepatocytes in the laboratory. This groundbreaking development could help advance a variety of liver-related research and applications, from studying drug toxicity to creating bio-artificial liver support for patients awaiting transplantations.
A study published recently in the journal Viruses has identified a potent diuretic ethacrynic acid as an efficient inhibitor of the main protease of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This drug can be potentially repurposed to treat coronavirus disease 2019 (COVID-19).
The Australian biotechnology company, Novogen Limited today announced receipt of funding from the FSHD Global Research Foundation as part of the Company's efforts to find effective treatments for a range of musculo-degenerative diseases including facioscapulohumeral dystrophy (FSHD).
The federal government must renew funding for the Aboriginal Diabetes Initiative (ADI) in next week's budget or more than 600 programs for Aboriginal Canadians living with diabetes are at risk of being shut down, according to the Canadian Diabetes Association and the National Aboriginal Diabetes Association (NADA).
Clinicians are challenged every day to make difficult decisions regarding patients' suicide risk. Using Veterans Health Administration health system electronic medical record data, Veterans Affairs and National Institute of Mental Health scientists were able to identify very small groups of individuals within the VHA's patient population with very high, predicted suicide risk - most of whom had not been identified for suicide risk by clinicians.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jean M Gerhard, MD 6130 W Parker Rd, Suite 106, Plano, TX 75093-7901 Ph: (972) 468-8158 | Dr Jean M Gerhard, MD 3004 Communications Pkwy, #200, Plano, TX 75093-8909 Ph: (972) 468-8158 |
News Archive
In new research appearing in the prestigious journal Nature Biotechnology, an international research team led by The Hebrew University of Jerusalem describes a new technique for growing human hepatocytes in the laboratory. This groundbreaking development could help advance a variety of liver-related research and applications, from studying drug toxicity to creating bio-artificial liver support for patients awaiting transplantations.
A study published recently in the journal Viruses has identified a potent diuretic ethacrynic acid as an efficient inhibitor of the main protease of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This drug can be potentially repurposed to treat coronavirus disease 2019 (COVID-19).
The Australian biotechnology company, Novogen Limited today announced receipt of funding from the FSHD Global Research Foundation as part of the Company's efforts to find effective treatments for a range of musculo-degenerative diseases including facioscapulohumeral dystrophy (FSHD).
The federal government must renew funding for the Aboriginal Diabetes Initiative (ADI) in next week's budget or more than 600 programs for Aboriginal Canadians living with diabetes are at risk of being shut down, according to the Canadian Diabetes Association and the National Aboriginal Diabetes Association (NADA).
Clinicians are challenged every day to make difficult decisions regarding patients' suicide risk. Using Veterans Health Administration health system electronic medical record data, Veterans Affairs and National Institute of Mental Health scientists were able to identify very small groups of individuals within the VHA's patient population with very high, predicted suicide risk - most of whom had not been identified for suicide risk by clinicians.
› Verified 8 days ago
Dr. Christy Washington Walker, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 6130 W Parker Rd Ste 204, Plano, TX 75093 Phone: 972-981-7861 Fax: 972-981-7862 | |
Surekha Machupalli, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 8901 Independence Pkwy, Plano, TX 75025 Phone: 972-908-2444 | |
Dr. Arlene Esther Garcia-soto, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 6957 W Plano Pkwy Ste 2000, Plano, TX 75093 Phone: 214-483-6933 Fax: 214-483-6648 | |
Dr. Katrina H Walsh, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1600 Coit Rd, Suite 402, Plano, TX 75075 Phone: 972-519-1900 Fax: 972-964-5323 | |
Dr. Nora L Hsu, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 5425 W Spring Creek Pkwy Ste 280, Plano, TX 75024 Phone: 972-867-6400 | |
Madhuri Gudipaty, M.D Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1600 Coit Rd, Suite 101, Plano, TX 75075 Phone: 972-867-7500 Fax: 972-578-7550 | |
Carol L. Brown-elliott, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 3901 W 15th St, #200, Plano, TX 75075 Phone: 972-519-1328 |